PERINI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 6.438
AS - Asia 2.570
EU - Europa 2.084
AF - Africa 681
SA - Sud America 562
OC - Oceania 51
Continente sconosciuto - Info sul continente non disponibili 32
Totale 12.418
Nazione #
US - Stati Uniti d'America 6.114
SG - Singapore 969
CN - Cina 481
IT - Italia 449
HK - Hong Kong 355
BR - Brasile 337
FI - Finlandia 214
DE - Germania 181
SE - Svezia 142
PL - Polonia 141
UA - Ucraina 136
VN - Vietnam 125
FR - Francia 107
RU - Federazione Russa 77
GB - Regno Unito 70
AR - Argentina 41
NL - Olanda 41
IN - India 36
IE - Irlanda 34
CA - Canada 31
IQ - Iraq 29
TR - Turchia 28
CO - Colombia 27
EC - Ecuador 27
JO - Giordania 27
KG - Kirghizistan 27
MA - Marocco 27
MD - Moldavia 27
BF - Burkina Faso 26
ID - Indonesia 26
JP - Giappone 26
MZ - Mozambico 26
MX - Messico 25
PH - Filippine 25
AT - Austria 24
BG - Bulgaria 24
BO - Bolivia 24
CV - Capo Verde 24
AO - Angola 23
CH - Svizzera 23
IS - Islanda 23
NI - Nicaragua 23
SO - Somalia 23
AZ - Azerbaigian 22
BE - Belgio 22
DJ - Gibuti 22
PK - Pakistan 22
RS - Serbia 22
AE - Emirati Arabi Uniti 21
BA - Bosnia-Erzegovina 21
BJ - Benin 21
ES - Italia 21
LV - Lettonia 21
SI - Slovenia 21
TZ - Tanzania 21
ZA - Sudafrica 21
DZ - Algeria 20
GF - Guiana Francese 20
GR - Grecia 20
MK - Macedonia 20
PS - Palestinian Territory 20
UZ - Uzbekistan 20
AL - Albania 19
AM - Armenia 19
CZ - Repubblica Ceca 19
GP - Guadalupe 19
HN - Honduras 19
KZ - Kazakistan 19
ML - Mali 19
NO - Norvegia 19
PE - Perù 19
PY - Paraguay 19
VE - Venezuela 19
BZ - Belize 18
GA - Gabon 18
KH - Cambogia 18
MU - Mauritius 18
MY - Malesia 18
PA - Panama 18
PR - Porto Rico 18
ZW - Zimbabwe 18
DO - Repubblica Dominicana 17
BY - Bielorussia 16
CL - Cile 16
CM - Camerun 16
CW - ???statistics.table.value.countryCode.CW??? 16
IL - Israele 16
LU - Lussemburgo 16
MR - Mauritania 16
NE - Niger 16
RE - Reunion 16
RO - Romania 16
SA - Arabia Saudita 16
SN - Senegal 16
TN - Tunisia 16
UG - Uganda 16
BD - Bangladesh 15
BW - Botswana 15
CG - Congo 15
CI - Costa d'Avorio 15
Totale 11.717
Città #
Woodbridge 625
Fairfield 619
Jacksonville 532
Singapore 504
Houston 467
Ann Arbor 466
Chandler 452
Ashburn 364
Hong Kong 338
Wilmington 303
Santa Clara 287
Cambridge 213
Seattle 204
Princeton 166
Boardman 155
Beijing 117
Bytom 104
San Diego 86
Medford 84
Nanjing 75
Padova 71
Helsinki 67
Munich 49
Los Angeles 46
Roxbury 46
Des Moines 45
Ho Chi Minh City 38
Buffalo 33
Rome 33
Dublin 29
Shenyang 28
Turku 27
New York 26
Amman 25
Jiaxing 25
Dong Ket 24
Nanchang 24
Bishkek 23
Managua 22
Milan 22
Ouagadougou 22
Baku 21
Hebei 21
Chicago 20
Dar es Salaam 20
Hanoi 20
Praia 20
Reykjavik 20
Djibouti 19
Riga 19
São Paulo 19
Bamako 18
Guangzhou 18
Phnom Penh 18
Tashkent 18
Brooklyn 16
Cayenne 16
Chisinau 16
Cotonou 16
Harare 16
Kampala 16
Libreville 16
Luanda 16
Maputo 16
Redondo Beach 16
Willemstad 16
Abidjan 15
Florence 15
Kigali 15
Lima 15
Lusaka 15
Norwalk 15
Panama City 15
Tianjin 15
Ulan Bator 15
Vienna 15
Warsaw 15
Yerevan 15
Amsterdam 14
Belgrade 14
Dakar 14
Hefei 14
Nouakchott 14
Changsha 13
Conakry 13
Kingstown 13
La Paz 13
Ljubljana 13
Nairobi 13
Niamey 13
Accra 12
Athens 12
Banjul 12
Bridgetown 12
Dili 12
Dushanbe 12
Kuala Lumpur 12
Medellín 12
Minsk 12
Vientiane 12
Totale 7.794
Nome #
Italian validation of the Symptom Rating Test (SRT) and Symptom Questionnaire (SQ). 361
The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression 287
Genome-wide scan supports the existence of a susceptibility locus for schizophrenia and bipolar disorder on chromosome 15q26 220
Cognitive effects of long-term interferon treatment for chronic viral hepatitis 196
Analysis of complete mitochondrial genomes of patients with schizophrenia and bipolar disorder. 192
Cognitive effects of long-term interferon treatment for chronic viral hepatitis 187
Influence of coping skills on health-related quality of life in patients with systemic lupus erythematosus 182
Reduced right posterior hippocampal volume in women with recurrent familial pure depressive disorder 179
Is a high dosage aripiprazole-clozapine combination an effective strategy for treatment-resistant schizophrenic patients? A case report. 171
Hippocampal remodelling after MDMA neurotoxicity: a single case study 160
Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia 152
Mood, cognition and EEG changes during interferon alpha (alpha-IFN) treatment for chronic hepatitis C. 148
HEART RATE VARIABILITY PARALLELS CHANGES IN PSYCHIATRIC SCALES IN INTERFERON-TREATED PATIENTS WITH CHRONIC HEPATITIS 143
Cognitive and psychiatric evaluation of 40 patients with myotonic dystrophy. 142
Research diagnostic criteria (RDC) mental disorder and self-reported symptoms in outpatients with complex partial seizures (CPS). 142
The lithium loading dose method in a clinical setting. 142
Vagus Nerve Stimulation in Treatment-Resistant Depression: A Case Series of Long-Term Follow-up 141
Volumetric MRI analysis of hippocampal subregions in Cushing’s disease: A model for glucocorticoid neural modulation 140
Life events and alopecia areata. 139
Late-onset OCD as presenting manifestation of semantic dementia. 138
The metyrapone test in manic patients and healthy subjects. 136
Hostility and recovery from melancholia. 135
Plasma concentrations of anxiolytic neuroactive steroids in men with panic disorder 133
Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants 132
Noradrenergic receptor sensitivity in obsessive compulsive disorder: II. Cortisol response to acute clonidine administration. 132
Hypochondriacal fears and beliefs in DSM-III melancholia. Changes with amitriptyline. 132
Evaluation of linkage signals in a subset of families with high recurrence of schizophrenia and bipolar disorder originating from Chioggia 131
Effects of carbamazepine on pituitary-adrenal function in healthy volunteers 131
Genome scan for schizophrenia/bipolar disorder supports a susceptibility locus in 15q26 131
Aripiprazole in acute mania and long-term treatment of bipolar disorder. A critical review by an Italian Working group 130
Multiple-dose pharmacokinetics of imipramine and its major active and conjugated metabolites in depressed patients. 128
The metyrapone test in schizophrenic patients and healthy subjects. 127
Noradrenergic receptor sensitivity in obsessive-compulsive disorders: I Growth hormone Response to Clonidine stimulation 126
Interictal Mood and Personality Disorders in complex partial epilepsy and Juvenile Myoclonic Epilepsy 123
The dexamethasone suppression and metyrapone tests in depression. 123
Cognitive Impairment and (CTG)n expansion in myotonic dystrophy patients 122
Psychoimmunoendocrine aspects of panic disorder 122
Cognitive disorders and cerebral perfusion abnormalities in SLE 121
The metyrapone test in depressed males. 120
Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of age 120
Paroxetine in alopecia areata 118
Heart rate variability parallels changes in psychiatric scales in interferon-treated patients with chronic hepatitis. 118
Depression and anxiety in complex partial seizures. 117
Recurrent major depression and Cushing's disease: Project for a volumetric study 116
Time- and dose-dependent effects of corticotropin releasing factor on cerebral glucose metabolism in rats 116
Changes in neuroactive steroid secretion associated with CO2-induced panic attacks in normal individuals 116
The cognitive effects of long-term interferon treatment for chronic viral hepatitis 116
The metyrapone test in affective disorders and schizophrenia. 112
Rating depression in normals and depressives: observer versus self-rating scales. 110
Il disturbo bipolare 109
A naturalistic study comparing two initial duloxetine dosing strategies in a clinical "real world" setting 109
Emotions and personality in complex partial seizures. 108
The metyrapone test in affective disorders and schizophrenia II. Changes upon treatment. 107
Health-related quality of life in Italian patients with systemic lupus erythematosus 106
Multiple perforating lesions and chronic daily headache:a case report 106
Life events and psychological distress in dermatologic disorders: psoriasis, chronic urticaria and fungal infections. 106
Neurobiologia dell'aggressività  104
Neurotoxychological Monitoring of Interferon treatment in Viral Hepatitis: a Pilot Sudy 100
IFN treatment in viral Hepatitis really affect mood and cognition? Neuropsychological Changes and Electrophysiological correlates 100
Intellectual Impairment and cognitiver evoked potentials in myotonic dystrophy 94
HEART RATE VARIABILITY PARALLELS CHANGES IN PSYCHIATRIC SCALES IN INTERFERON-TREATED PATIENTS WITH CHRONIC HEPATITIS. 94
Late-onset affective and psychotic disorders: The challenge of disentangling neurodegenerative diseases from primary psychiatric disorders 93
CLINICAL OBSERVATIONS ON PANIC DISORDERS 92
Neurophysiological bases of IFN toxicity in the treatment of viral hepatitis: Psychiatric, cognitive changes and long-term electrophysiological correlates. 92
Prefrontal dysfunction in cirrhotic patients without overt hepatic encephalopathy decteted by the Stroop Test 91
The neurosteroid modulation of normal and pathological anxiety in humans 91
Genetic inheritance of schizophrenia and bipolar disorder in an italian population isolate 89
Major depressive disorders and coronary artery disease: a review on common pathophysiological pathways 88
NEUROCYTOKYNES CHANGES INDUCING PEG-INTERFERON-ALPHA DEPRESSION: A RATIONAL APPROACH TO INCREASE ADHERENCE OF THERAPY IN CHRONIC HEPATITIS C 86
Psychiatric effects of conventional interferon versus pegilated interferon in chronic hepatitis patients after two and six months of therapy 86
Recurrent Major Depression and Nuclear Magnetic Resonance: A volumetric study, 85
Multiple cerebral perforating lesions and chronic daily headache: a case report 85
Uso della paroxetina nell'alopecia areata 84
Studio prospettico osservazionale sull'incidenza del disturbo depressivo in pazienti affetti da malattia coronarica acuta e valutazione del decorso del disturbo depressivo 84
Neurotrofine e RMN Cerebrale nel Disturbo Depressivo Maggiore, 83
EFFECTS OF ANTIPSYCHOTIC TREATMENTS ON SERUM PROLACTINE LEVELS. A COMPARATIVE NATURALISTIC STUDY 83
Basi neurologiche e aspetti clinici della depressione ricorrente 82
Characterization of a 7% carbon dioxide (C02) inhalation paradigm to evoke anxiety symptoms in healthy subjects 82
Carbamazepine: a bridge between epilepsy and psychiatry 82
Il dolore interiore (o il dolore in psichiatria) 81
La psicoeducazione nei disturbi bipolari 80
La qualità  della vita nel lupus eritematoso sistemico. 80
Carbamazepine: A bridge between epilepsy and psychiatric disorders. Premises 78
NEUROCYTOKYNES CHANGES INDUCING PEG-INTERFERON-ALPHA DEPRESSION: A RATIONAL APPROACH TO INCREASE ADHERENCE OF THERAPY IN CHRONIC HEPATITIS C. 78
ESAMI BIOUMORALI E STRUMENTALI IN PSICHIATRIA 77
Stress-responsive neurohormonal systems and the symptom complex of affective illness. 74
[Affective disorders in general hospitals: the organic affective syndrome]. 74
Plasma interleukin-beta and tumor necrosis factor concentrations in obsessive-compulsive disorders 73
Carbamazepine. A bridge between epilepsy and psychiatric disorders 73
Capitolo 5 Schizofrenia: 73
Capitolo 9: I Disturbi dell'Umore 72
LA BUONA PRATICA PRESCRITTIVA IN PSICOFARMACOLOGIA 72
Effetti neuropsichiatrici della terapia con interferon: uno studio prospettico di confronto tra PEG-IFN ed IFN α 72
Preventing interferon-induced depression in a sample of 44 chronic hepatitis C patients with risk factor for depression 71
[Schizophrenic and affective disorders in multiple sclerosis. Description of 2 clinical cases]. 69
I disturbi mentali organici 69
Effetti neuropsichiatrici dell'uso dell'interferone nel trattamento delle epatiti virali 67
Dal blocco del sistema nervoso vegetativo all’ibernazione artificiale: primi risultati di un nuovo indirizzo di terapia psichiatrica. La storia padovana della cloropromazina 67
Psicosi organiche I: Le psicosi esogene acute o delirium 67
Life Charting dei disturbi affettivi ricorrenti: Una guida completa alla valutazione clinica di Leverich GS e Post RM 66
Totale 11.490
Categoria #
all - tutte 36.261
article - articoli 27.706
book - libri 691
conference - conferenze 0
curatela - curatele 590
other - altro 294
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.871
Totale 70.413


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021618 0 0 0 0 49 97 33 72 138 51 108 70
2021/20221.182 13 225 110 119 21 91 54 121 37 12 123 256
2022/2023991 235 92 27 98 148 143 13 60 121 11 37 6
2023/2024435 22 69 62 36 19 30 16 20 19 12 60 70
2024/20252.198 17 153 95 93 431 58 85 111 196 81 376 502
2025/20263.588 275 646 1.151 1.204 312 0 0 0 0 0 0 0
Totale 12.438